The Nuvista Pharma acquisition is now consolidated and contributing to double-digit growth in the domestic market.Strong export growth continues, with the agreement to buy 8 new ANDAs from Sandoz doubling the Company’s US product portfolio.
03 Jul 2019
Export and domestic sales growth continue to impress
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Export and domestic sales growth continue to impress
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON) | 37.0 0.2 1.4% | Mkt Cap: 165.1m
- Published:
03 Jul 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
33
The Nuvista Pharma acquisition is now consolidated and contributing to double-digit growth in the domestic market.Strong export growth continues, with the agreement to buy 8 new ANDAs from Sandoz doubling the Company’s US product portfolio.